Northern Trust Corp Travere Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 808,687 shares of TVTX stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
808,687
Previous 754,395 7.2%
Holding current value
$13.4 Million
Previous $13.1 Million 10.27%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$17.07 - $23.75 $926,764 - $1.29 Million
54,292 Added 7.2%
808,687 $14.5 Million
Q4 2024

Feb 14, 2025
BUY
$13.65 - $19.85 $1.04 Million - $1.52 Million
76,358 Added 11.26%
754,395 $13.1 Million
Q3 2024

Nov 13, 2024
SELL
$7.89 - $15.21 $209,282 - $403,445
-26,525 Reduced 3.76%
678,037 $9.49 Million
Q2 2024

Aug 14, 2024
SELL
$5.26 - $8.28 $102,396 - $161,186
-19,467 Reduced 2.69%
704,562 $5.79 Million
Q1 2024

May 14, 2024
SELL
$7.18 - $9.82 $43,920 - $60,068
-6,117 Reduced 0.84%
724,029 $5.58 Million
Q4 2023

Feb 13, 2024
BUY
$5.44 - $9.5 $218,285 - $381,197
40,126 Added 5.82%
730,146 $6.56 Million
Q3 2023

Nov 13, 2023
BUY
$7.64 - $17.25 $44,976 - $101,550
5,887 Added 0.86%
690,020 $6.17 Million
Q2 2023

Aug 11, 2023
SELL
$15.3 - $22.61 $103,550 - $153,024
-6,768 Reduced 0.98%
684,133 $10.5 Million
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $965,416 - $1.24 Million
54,176 Added 8.51%
690,901 $15.5 Million
Q4 2022

Feb 13, 2023
BUY
$18.47 - $26.14 $84,592 - $119,721
4,580 Added 0.72%
636,725 $13.4 Million
Q3 2022

Nov 14, 2022
SELL
$22.91 - $28.63 $100,093 - $125,084
-4,369 Reduced 0.69%
632,145 $15.6 Million
Q2 2022

Aug 12, 2022
BUY
$20.94 - $30.01 $214,718 - $307,722
10,254 Added 1.64%
636,514 $15.4 Million
Q1 2022

May 13, 2022
BUY
$23.61 - $30.6 $1.66 Million - $2.16 Million
70,464 Added 12.68%
626,260 $16.1 Million
Q4 2021

Feb 08, 2022
SELL
$24.34 - $31.17 $117,294 - $150,208
-4,819 Reduced 0.86%
555,796 $17.3 Million
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $754,527 - $1.45 Million
-58,130 Reduced 9.39%
560,615 $13.6 Million
Q2 2021

Aug 13, 2021
SELL
$14.11 - $26.4 $312,903 - $585,446
-22,176 Reduced 3.46%
618,745 $9.03 Million
Q1 2021

May 12, 2021
BUY
$23.37 - $31.77 $608,180 - $826,782
26,024 Added 4.23%
640,921 $16 Million
Q4 2020

Feb 11, 2021
BUY
$19.17 - $27.87 $11.8 Million - $17.1 Million
614,897 New
614,897 $16.8 Million

Others Institutions Holding TVTX

# of Institutions
239
Shares Held
99.9M
Call Options Held
1.79M
Put Options Held
555K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.07B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email